- Future Students
- Current Students
- Faculty & Staff
Filters: Keyword is Cancer Vaccines [Clear All Filters]
Dolan BP, Gibbs KD, Ostrand-Rosenberg S. 2006. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.. Journal of immunology (Baltimore, Md. : 1950). 176(3):1447-55.
Dolan BP, Phelan TP, Ilkovitch D, Qi L, Wade WF, Laufer TM, Ostrand-Rosenberg S. 2004. Invariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines.. Journal of immunology (Baltimore, Md. : 1950). 172(2):907-14.
Moulton HM, Yoshihara PH, Mason DH, Iversen PL, Triozzi PL. 2002. Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival.. Clinical cancer research : an official journal of the American Association for Cancer Research. 8(7):2044-51.